G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
July 2010...B+L Voluntarily Recalls ReNu Multi-Purpose Solution
July 10, 2010
B+L Voluntarily Recalls Certain ReNu Multi-Purpose Solution and ReNu MultiPlus Multi-Purpose Solution in Europe and Middle East | www.visionmonday.com
No this is not 2007! A new problem has occurred in the manufacturing of Baucsh & Lomb's current signature contact lens disinfecting product, ReNu. Bausch has just released BioTrue, the next best product in Contact Lens care about 2 weeks ago.
Abbott back in contact lens solution game
June 12, 2010
Abbott back in contact lens solution game | www.chicagobreakingbusiness.com
There are new regulations and new contact lens solutions being announced almost weekly. Both Abbott and Bausch & Lomb have released new information on contact lens solutions. The industry leader Alcon's OptiFree with almost 33% of the retail US market should announce a new solution soon.
New Contact Lens Products in the Pipeline From J&J (JNJ)
June 4, 2010
UPDATE 3-J&J sees fast-growing device market | www.reuters.com
At the 2nd qtr reports for Johnson & Johnson Vision (JNJ) products a new announcement for allergy sufferers can lead to a new vehicle for introduction of medications in the eye, and the whole body.
Alcon Expanding Its Drug Offerings and Pipeline with 3 Medications
January 20, 2010
Alcon to purchase rights for two eye care products from Sirion Therapeutics | www.pharmabiz.com
The rights for the the new anti inflammatory medication Durezol is Hot. The rights for Zirgan is a much smaller market, but there is limited competition in that field.The New Dry Eye Syndrome medication for Ocular Surface Disease is the first potential since the blockbuster medication Restasis. This is undergoing clinical clinical testing now. There are one or two other Dry Eye Syndrome medications coming down the pipeline.
Alcon would make a nice prize for Novartis
January 4, 2010
Top News Bloomberg Novartis May Sell Bonds in 2010 for $28.2 Billion Alcon Deal | www.businessweek.com
It looks like Novartis AG is gearing up to purchase the rest of Alcon, Inc.
What happens to the "Lifetime" guarantee?
December 21, 2009
TLC Vision, Tiger Woods Sponsor, Files for Bankruptcy | www.bloomberg.com
TLC Vision Corp (TLC), The Laser Center, marketed their Lifetime touch up at no additional charge. What happens now that they have declared chapter 11 bankruptcy as of 12/21/2009?
Luxottica now Selling Contact Lenses Online, What is Next?
December 15, 2009
Luxottica and drugstore.com Form Strategic eCommerce Alliance to Expand Contact Lens Services in North America | money.cnn.com
Luxottica Group S.p.A.(NYSE: LUX) will be selling contact lenses in affiliation with one of the lowest priced online retailers in the USA Drugstore.com, inc.. They have a place in the vision insurance industry, eyeglass wholesale market, eyeglass retail market, hiring of eye doctors, sales of contact lenses in their stores and online.
Contact Lens Nirvana: Hyperpermeable One Day
October 2, 2009
Hobby assists Irish strategy | www.opticianonline.net
This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.
Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
July 23, 2009
Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com
This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.
A drop in the price of OTC allergy eye drops?
July 5, 2009
Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’ | Top News | www.topnews.in
By adding a third OTC antihistamine eye drop to the mix the price competition should make the cost to the consumer decrease.
Laser Vision Correction for Presbyopia is here!
April 6, 2009
Presbyopic laser vision correction reduces spectacle dependence in pseudophakes | www.modernmedicine.com
The missing element in LVC today is real multifocal correction to deal with a the large population of baby boomers that are finding a need for a different correction for distance vision than near vision(most people over 40 years of age). As of now we have only two options for adults: 1) two eyes corrected for distance vision and reading glasses or 2) mono-vision, one eye corrected for near, and the other corrected for distance vision. We currently have the ability to create mulitfocal spectacle lenses, and multifocal contact lenses. Johnson & Johnson's Vistakon just released a new Acuvue for Presbyopia in March 2009, CooperVision and Bausch & Lomb have both had multifocal contact lenses for years.
Will contact lens solutions cost more to ship and store?
November 13, 2008
Eye Infection Epidemic Traced To Reduced Antifungal Properties Of Contact Lens Solution In High Temperatures | www.medicalnewstoday.com
A new study in Archives of Ophthalmology, November 2008 indicates that a reason for the large number of infections from Bausch & Lomb's Renu Moisture Loc solution was due to poor temperature control reducing antifungal and antimicrobial efficacy.
Lasik, Pharma, and Cataracts...are they recession proof?
November 4, 2008
Value Stocks in the Eye of the Storm? | news.morningstar.com
The article goes into the four major eye care markets that have a mix of reimbursed, and consumer driven areas. It describes the issues I face as a provider of these products.
A new lens for computer users?
October 6, 2008
PixelOptics focuses on new lens | www.roanoke.com
This eyeglass lens designer, Ron Blum has created a new type of Progressive Addition Lens about 6 years ago. It created a new market in Ultra-Premium lenses. Now he is attempting to create a new lens for computer users. I look forward to its introduction next month, and to the creation of new profit opportunity from selling his new design.
Working with Silcione Hydrogels is not easy!
September 22, 2008
Ahead of the Bell: Cooper Cos. | www.forbes.com
This article mentions two major contact lens manufacturers, CooperVision and Vistakon (a subsidiary of Johnson & Johnson), with difficulties actually making silicone hydrogel contact lenses that can be sold successfully.
A new Contact Lens material by 2009?
September 22, 2008
Ocutec wins backing for contact lens venture | www.theherald.co.uk
A new material that is easier to produce contact lenses with may decrease the cost of producing contact lenses. A major difficulty in producing today's silicone hydrogels is production costs.
New non steroidal anti-inflamatory for diabetic retinopathy?
August 26, 2008
Pfizer Inc. Cancels Phase III of Glaucoma Drug Research in Asia | www.biospace.com
The new prostaglandin analog is not what i find interesting in this article. A new treatment for Diabetic Retinopathy sounds much more interesting
An illegal use of Lumigan, now legal?
July 3, 2008
Longer Lashes in a Tube? Maybe Not | www.nytimes.com
A few months ago, a small company tried to import Lumigan (bimatoprost), licensed by Allergan, in an eyelash applicator. It was held by the FDA as an unapproved use of a prescription medication. Now the owner of the patent is trying to import the same drug legally.
Announcing the 1-Day Acuvue TruEye a New Silicone Hydrogel Contact Lens
June 3, 2008
Johnson & Johnson Vision Care Announces First Daily Disposable Silicone Hydrogel at BCLA | www.cltoday.com
This is the first announcement anywhere in the world about a daily disposable contact lens that is in a breathable silicone hydrogel material. Will it make it across the ocean?
Will The Avaira Take Market Share From Oaysis?
May 15, 2008
CooperVision Introduces Avaira™ Two-Week Silicone Hydrogel Contact Lenses | www.coopervision.com
Can Cooper take over the 2 week spherical contact lens market? Can it make a dent in the market share of the industry leader in the silicone hydrogel field? Initial results look good. A definite maybe!
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011